The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, current, and standardized global evidence on the cost of delivering vaccines. In January 2017 and again in April 2018 and December 2019, ThinkWell completed a systematic review of the current evidence base on immunization delivery costs (IDC)*. The IDCC was built to answer a question … Continued
Focus Area: Evaluating cost and cost-effectiveness of immunization programs
Results 1 -10 of 24
Teaching Vaccine Economics Everywhere (TVEE) Course Materials
1. Health Economics for Vaccines The process of creating vaccines, manufacturing, distributing, and injecting them into individuals is a complex process requiring multiple decisions by multiple groups and individuals. On the supply side there are pharmaceutical companies, regulatory authorities, distributors, and thousands of health care workers who have to make strategic choices. On the demand side … Continued
ProVac Toolkit: Providing Tools to Support Vaccine Decision Making at Country-level
PAHO’s ProVac Initiative helps national immunization programs managers and policymakers make more robust, evidence based decisions. Since 2004, the ProVac Initiative and its collaborators have trained hundreds of people at ministries of health in the Americas and elsewhere on the development and use of vaccine impact, cost and cost-effectiveness data to inform decision making. More … Continued
Papillomavirus Rapid Interface for Modelling and Economics (PRIME) Tool
The spreadsheet-based PRIME tool is intended for in-country analysts (not necessarily economists) who are advising national governments on HPV vaccine introduction. PRIME is designed to give users an idea of: The magnitude of the burden of cervical cancer The impact of introducing HPV vaccination for girls prior to sexual debut Healthcare costs incurred as a … Continued
Teaching Vaccine Economics Everywhere (TVEE) Capacity Building Training in Vaccine Economics
02/11/2020
The Teaching Vaccine Economics Everywhere (TVEE) project announces the launch of the first workshops of the series in Bangkok, Thailand. The workshop series focuses on capacity building in applied vaccine economics, cost-effectiveness and finance. The workshop series will be held at the Faculty of Pharmacy in Mahidol University, and will cover topics in Vaccine Economics, … Continued
Re-evaluating the Potential Impact and Cost-effectiveness of Rotavirus Vaccination in 73 Gavi Countries: A Modelling Study
Background Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration of follow-up), new rotavirus vaccines have entered the market, vaccine prices have decreased, and cost-effectiveness thresholds have … Continued
Rotavirus Vaccination is Cost Effective and Saves Lives, New Analysis Finds
In an analysis published in the December issue of The Lancet Global Health, investigators from PATH, the London School of Hygiene & Tropical Medicine, and the US Centers for Disease Control and Prevention, analyzed the potential costs of rotavirus vaccination for 10 successive birth cohorts (from 2018 through 2027) in 73 countries eligible for Gavi support, compared … Continued
WHO Guide for Standardization of Economic Evaluations of Immunization Programs
WHO has recently published a new edition of the guidance to meet the increased need to carry out immunization economic evaluations for decision making using the latest methodologies. This updated guide brings together the recommendations and guidance from many recent guidelines, tools and other documents on specific aspects of immunization and on specific vaccines. The … Continued
The Costs of Delivering Vaccines in Low- and Middle-income Countries: Findings from a Systematic Review
Abstract Information on immunization delivery costs (IDCs) is essential for better planning and budgeting for the sustainability and performance of national programs. However, delivery cost evidence is fragmented and of variable quality, making it difficult for policymakers, planners, and other stakeholders to understand and use. This study aimed to consolidate and summarize the evidence on … Continued
Updated Analyses on Immunization Delivery Costs now Available at immunizationeconomics.org/ICAN
In May 2018, ThinkWell released findings from a systematic review of the evidence base on immunization delivery costs (IDC) in low- and middle-income countries (LMICs). The review aimed to answer a question frequently asked by global and country immunization stakeholders: What are the unit costs of vaccine delivery across different LMICs and through a variety … Continued